263 related articles for article (PubMed ID: 31108370)
1. SIRT3 regulates cancer cell proliferation through deacetylation of PYCR1 in proline metabolism.
Chen S; Yang X; Yu M; Wang Z; Liu B; Liu M; Liu L; Ren M; Qi H; Zou J; Vucenik I; Zhu WG; Luo J
Neoplasia; 2019 Jul; 21(7):665-675. PubMed ID: 31108370
[TBL] [Abstract][Full Text] [Related]
2. Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis.
Ding Z; Ericksen RE; Escande-Beillard N; Lee QY; Loh A; Denil S; Steckel M; Haegebarth A; Wai Ho TS; Chow P; Toh HC; Reversade B; Gruenewald S; Han W
J Hepatol; 2020 Apr; 72(4):725-735. PubMed ID: 31726117
[TBL] [Abstract][Full Text] [Related]
3. Human mitochondrial pyrroline-5-carboxylate reductase 1 promotes invasiveness and impacts survival in breast cancers.
Ding J; Kuo ML; Su L; Xue L; Luh F; Zhang H; Wang J; Lin TG; Zhang K; Chu P; Zheng S; Liu X; Yen Y
Carcinogenesis; 2017 May; 38(5):519-531. PubMed ID: 28379297
[TBL] [Abstract][Full Text] [Related]
4. CRIF1 promotes the progression of non-small-cell lung cancer by SIRT3- mediated deacetylation of PYCR1.
Wang Q; Xie Z; Li C; Xu C; Ding C; Ju S; Chen J; Cui Z; Chen C; Gu B; Wei T; Zhao J
J Mol Histol; 2022 Aug; 53(4):657-667. PubMed ID: 35716330
[TBL] [Abstract][Full Text] [Related]
5. Genetic analysis of Pycr1 and Pycr2 in mice.
Stum MG; Tadenev ALD; Seburn KL; Miers KE; Poon PP; McMaster CR; Robinson C; Kane C; Silva KA; Cliften PF; Sundberg JP; Reinholdt LG; John SWM; Burgess RW
Genetics; 2021 May; 218(1):. PubMed ID: 33734376
[TBL] [Abstract][Full Text] [Related]
6. Resolving the cofactor-binding site in the proline biosynthetic enzyme human pyrroline-5-carboxylate reductase 1.
Christensen EM; Patel SM; Korasick DA; Campbell AC; Krause KL; Becker DF; Tanner JJ
J Biol Chem; 2017 Apr; 292(17):7233-7243. PubMed ID: 28258219
[TBL] [Abstract][Full Text] [Related]
7. Kindlin-2 links mechano-environment to proline synthesis and tumor growth.
Guo L; Cui C; Zhang K; Wang J; Wang Y; Lu Y; Chen K; Yuan J; Xiao G; Tang B; Sun Y; Wu C
Nat Commun; 2019 Feb; 10(1):845. PubMed ID: 30783087
[TBL] [Abstract][Full Text] [Related]
8.
Christensen EM; Bogner AN; Vandekeere A; Tam GS; Patel SM; Becker DF; Fendt SM; Tanner JJ
J Biol Chem; 2020 Dec; 295(52):18316-18327. PubMed ID: 33109600
[TBL] [Abstract][Full Text] [Related]
9. PINCH-1 regulates mitochondrial dynamics to promote proline synthesis and tumor growth.
Guo L; Cui C; Wang J; Yuan J; Yang Q; Zhang P; Su W; Bao R; Ran J; Wu C
Nat Commun; 2020 Oct; 11(1):4913. PubMed ID: 33004813
[TBL] [Abstract][Full Text] [Related]
10. Proline synthesis through PYCR1 is required to support cancer cell proliferation and survival in oxygen-limiting conditions.
Westbrook RL; Bridges E; Roberts J; Escribano-Gonzalez C; Eales KL; Vettore LA; Walker PD; Vera-Siguenza E; Rana H; Cuozzo F; Eskla KL; Vellama H; Shaaban A; Nixon C; Luuk H; Lavery GG; Hodson DJ; Harris AL; Tennant DA
Cell Rep; 2022 Feb; 38(5):110320. PubMed ID: 35108535
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic modification facilitates proline synthase PYCR1 aberrant expression in gastric cancer.
Xiao S; Yao X; Ye J; Tian X; Yin Z; Zhou L
Biochim Biophys Acta Gene Regul Mech; 2022 Aug; 1865(6):194829. PubMed ID: 35654390
[TBL] [Abstract][Full Text] [Related]
12. SIRT3 Overexpression Inhibits Growth of Kidney Tumor Cells and Enhances Mitochondrial Biogenesis.
Liu H; Li S; Liu X; Chen Y; Deng H
J Proteome Res; 2018 Sep; 17(9):3143-3152. PubMed ID: 30095923
[TBL] [Abstract][Full Text] [Related]
13. Structure, biochemistry, and gene expression patterns of the proline biosynthetic enzyme pyrroline-5-carboxylate reductase (PYCR), an emerging cancer therapy target.
Bogner AN; Stiers KM; Tanner JJ
Amino Acids; 2021 Dec; 53(12):1817-1834. PubMed ID: 34003320
[TBL] [Abstract][Full Text] [Related]
14. Deacetylation of HSD17B10 by SIRT3 regulates cell growth and cell resistance under oxidative and starvation stresses.
Liu L; Chen S; Yu M; Ge C; Ren M; Liu B; Yang X; Christian TW; Hou YM; Zou J; Zhu WG; Luo J
Cell Death Dis; 2020 Jul; 11(7):563. PubMed ID: 32703935
[TBL] [Abstract][Full Text] [Related]
15. Regulation of mitochondrial F(o)F(1)ATPase activity by Sirt3-catalyzed deacetylation and its deficiency in human cells harboring 4977bp deletion of mitochondrial DNA.
Wu YT; Lee HC; Liao CC; Wei YH
Biochim Biophys Acta; 2013 Jan; 1832(1):216-27. PubMed ID: 23046812
[TBL] [Abstract][Full Text] [Related]
16. Zebrafish Carrying
Liang ST; Audira G; Juniardi S; Chen JR; Lai YH; Du ZC; Lin DS; Hsiao CD
Cells; 2019 May; 8(5):. PubMed ID: 31091804
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic IDH1 Mutations Promote Enhanced Proline Synthesis through PYCR1 to Support the Maintenance of Mitochondrial Redox Homeostasis.
Hollinshead KER; Munford H; Eales KL; Bardella C; Li C; Escribano-Gonzalez C; Thakker A; Nonnenmacher Y; Kluckova K; Jeeves M; Murren R; Cuozzo F; Ye D; Laurenti G; Zhu W; Hiller K; Hodson DJ; Hua W; Tomlinson IP; Ludwig C; Mao Y; Tennant DA
Cell Rep; 2018 Mar; 22(12):3107-3114. PubMed ID: 29562167
[TBL] [Abstract][Full Text] [Related]
18. Expression and kinetic characterization of PYCR3.
Meeks KR; Tanner JJ
Arch Biochem Biophys; 2023 Jan; 733():109468. PubMed ID: 36414121
[TBL] [Abstract][Full Text] [Related]
19. Advances in characterization of SIRT3 deacetylation targets in mitochondrial function.
Wang S; Zhang J; Deng X; Zhao Y; Xu K
Biochimie; 2020 Dec; 179():1-13. PubMed ID: 32898647
[TBL] [Abstract][Full Text] [Related]
20. CDK1-Mediated SIRT3 Activation Enhances Mitochondrial Function and Tumor Radioresistance.
Liu R; Fan M; Candas D; Qin L; Zhang X; Eldridge A; Zou JX; Zhang T; Juma S; Jin C; Li RF; Perks J; Sun LQ; Vaughan AT; Hai CX; Gius DR; Li JJ
Mol Cancer Ther; 2015 Sep; 14(9):2090-102. PubMed ID: 26141949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]